Ziconotide
Neurological
A synthetic peptide from cone snail venom. FDA-approved for severe chronic pain via intrathecal delivery.
Community
0
Tracking
0
Doses Logged
0.1mcg/hr intrathecal
Common Dose
—
Adverse Rate
All dosages:0.1mcg/hr intrathecal2.4mcg/day intrathecal
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience